Characteristic features of the observed MM2 (CD64high) phenotype are associated with advanced-stage disease and myeloma-defining events, including hypercalcemia and elevated involved-to-uninvolved free light chain ratio. The gene discussed is TNFSF14; the disease is hypercalcemia disease.